{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:53:28Z","timestamp":1789138408345,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-106969RB-I00"],"award-info":[{"award-number":["PID2019-106969RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["IC190100020"],"award-info":[{"award-number":["IC190100020"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomech Model Mechanobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10237-024-01900-z","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T04:54:48Z","timestamp":1739508888000},"page":"383-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimisation of romosozumab plus denosumab sequential treatments against postmenopausal osteoporosis. Insights from in silico simulations"],"prefix":"10.1007","volume":"24","author":[{"given":"Roc\u00edo","family":"Ruiz-Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Calvo-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pivonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00ednez-Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"1900_CR1","doi-asserted-by":"publisher","unstructured":"Adami G, Pedrollo E, Rossini M, Fassio A, Braga V, Pasetto E, Pollastri F, Benini C, Viapiana O, Gatti D (2024) Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study. JMBR Plus 8(4):016. https:\/\/doi.org\/10.1093\/jbmrpl\/ziae016","DOI":"10.1093\/jbmrpl\/ziae016"},{"issue":"1","key":"1900_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/jcm10010152","volume":"10","author":"AD Anastasilakis","year":"2021","unstructured":"Anastasilakis AD, Makras P, Yavropoulou MP, Tabacco G, Naciu AM, Palermo A (2021) Denosumab discontinuation and the rebound phenomenon: a narrative review. J Clin Med 10(1):152. https:\/\/doi.org\/10.3390\/jcm10010152","journal-title":"J Clin Med"},{"issue":"12","key":"1900_CR3","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/jbmr.479","volume":"26","author":"MSM Ardawi","year":"2011","unstructured":"Ardawi MSM, Al-Kadi HA, Rouzi AA, Qari MH (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 26(12):2812\u20132822. https:\/\/doi.org\/10.1002\/jbmr.479","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1900_CR4","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1038\/s41598-021-82502-y","volume":"11","author":"M Ashrafi","year":"2021","unstructured":"Ashrafi M, Ghalichi F, Mirzakouchaki B, Doblar\u00e9 M (2021) On the effect of antiresorptive drugs on the bone remodeling of the mandible after dental implantation: a mathematical model. Sci Rep 11(1):2792. https:\/\/doi.org\/10.1038\/s41598-021-82502-y","journal-title":"Sci Rep"},{"key":"1900_CR5","doi-asserted-by":"publisher","unstructured":"Bone HG, Bolognese MA, Yuen CK, Kendler DL, Miller PD, Yang YC, Grazette L, San Martin J, Gallagher JC (2011) Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab 96(4):972\u2013980. https:\/\/doi.org\/10.1210\/jc.2010-1502","DOI":"10.1210\/jc.2010-1502"},{"issue":"3","key":"1900_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/jcb.240550312","volume":"55","author":"LF Bonewald","year":"1994","unstructured":"Bonewald LF, Dallas SL (1994) Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55(3):350\u2013357. https:\/\/doi.org\/10.1002\/jcb.240550312","journal-title":"J Cell Biochem"},{"issue":"12","key":"1900_CR7","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.1074\/jbc.M109.092130","volume":"285","author":"E Bourhis","year":"2010","unstructured":"Bourhis E, Tam C, Franke Y, Bazan JF, Ernst J, Hwang J, Costa M, Cochran AG, Hannoush RN (2010) Reconstitution of a Frizzled8$$\\cdot$$Wnt3a$$\\cdot$$LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6. J Biol Chem 285(12):9172\u20139179. https:\/\/doi.org\/10.1074\/jbc.M109.092130","journal-title":"J Biol Chem"},{"issue":"2","key":"1900_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Archiv Biochem Biophys 473(2):139\u2013146. https:\/\/doi.org\/10.1016\/j.abb.2008.03.018","journal-title":"Archiv Biochem Biophys"},{"key":"1900_CR9","doi-asserted-by":"publisher","unstructured":"Bregoli C, Biffi CA, Tuissi A, Buccino F (2024) Effect of trabecular architectures on the mechanical response in osteoporotic and healthy human bone. Med Biol Eng Comput (Ahead of print), https:\/\/doi.org\/10.1007\/s11517-024-03134-8","DOI":"10.1007\/s11517-024-03134-8"},{"key":"1900_CR10","doi-asserted-by":"publisher","first-page":"1060158","DOI":"10.3389\/fbioe.2023.1060158","volume":"11","author":"JL Calvo-Gallego","year":"2023","unstructured":"Calvo-Gallego JL, Manchado-Morales P, Pivonka P, Mart\u00ednez-Reina J (2023) Spatio-temporal simulations of bone remodelling using a bone cell population model based on cell availability. Front Bioeng Biotechnol 11:1060158. https:\/\/doi.org\/10.3389\/fbioe.2023.1060158","journal-title":"Front Bioeng Biotechnol"},{"key":"1900_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.940620","volume":"10","author":"JL Calvo-Gallego","year":"2022","unstructured":"Calvo-Gallego JL, Pivonka P, Ruiz-Lozano R, Mart\u00ednez-Reina J (2022) Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response. Front Bioeng Biotechnol 10:940620. https:\/\/doi.org\/10.3389\/fbioe.2022.940620","journal-title":"Front Bioeng Biotechnol"},{"key":"1900_CR12","doi-asserted-by":"publisher","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CAF, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. New Engl J Med 375(16):1532\u20131543. https:\/\/doi.org\/10.1056\/NEJMoa1607948","DOI":"10.1056\/NEJMoa1607948"},{"key":"1900_CR13","doi-asserted-by":"publisher","unstructured":"Cosman F, Crittenden DB, Ferrari S, Khan A, Lane NE, Lippuner K, Matsumoto T, Milmont CE, Libanati C, Grauer A (2018) FRAME study: The foundation effect of building bone with 1 year of romosozumab leads to continued lower fracture risk after transition to denosumab. J Bone Miner Res 33(7):1219\u20131226. https:\/\/doi.org\/10.1002\/jbmr.3427","DOI":"10.1002\/jbmr.3427"},{"issue":"2","key":"1900_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jbmr.3051","volume":"32","author":"F Cosman","year":"2017","unstructured":"Cosman F, Nieves JW, Dempster DW (2017) Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis. J Bone Miner Res 32(2):198\u2013202. https:\/\/doi.org\/10.1002\/jbmr.3051","journal-title":"J Bone Miner Res"},{"key":"1900_CR15","doi-asserted-by":"publisher","unstructured":"Eastell R, Black DM, Lui LY, Chines A, Marin F, Khosla S, de Papp AE, Cauley JA, Mitlak B, McCulloch CE, Vittinghoff E, Bauer DC (2021) Treatment-related changes in bone turnover and fracture risk reduction in clinical trials of antiresorptive drugs: proportion of treatment effect explained. J Bone Miner Res 36(2):236\u2013243. https:\/\/doi.org\/10.1002\/jbmr.4178","DOI":"10.1002\/jbmr.4178"},{"key":"1900_CR16","unstructured":"Evenity (romosozumab) [Package insert], Thousand Oaks, CA: Amgen Inc (2019) https:\/\/www.pi.amgen.com\/-\/media\/Project\/Amgen\/Repository\/pi-amgen-com\/evenity\/evenity_pi_hcp_english.ashx"},{"issue":"2\u20133","key":"1900_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10237-005-0067-x","volume":"4","author":"J Garc\u00eda-Aznar","year":"2005","unstructured":"Garc\u00eda-Aznar J, Rueberg T, Doblar\u00e9 M (2005) A bone remodelling model coupling microdamage growth and repair by 3D BMU-activity. Biomech Model Mechanobiol 4(2\u20133):147\u2013167. https:\/\/doi.org\/10.1007\/s10237-005-0067-x","journal-title":"Biomech Model Mechanobiol"},{"issue":"9","key":"1900_CR18","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1359\/jbmr.2002.17.9.1662","volume":"17","author":"CJ Hernandez","year":"2002","unstructured":"Hernandez CJ, Beaupr\u00e9 GS, Marcus R, Carter DR (2002) Long-term predictions of the therapeutic equivalence of daily and less than daily alendronate dosing. J Bone Miner Res 17(9):1662\u20131666. https:\/\/doi.org\/10.1359\/jbmr.2002.17.9.1662","journal-title":"J Bone Miner Res"},{"key":"1900_CR19","unstructured":"Jacobs CR (1994) Numerical simulation of bone adaptation to mechanical loading. PhD thesis, Stanford University"},{"key":"1900_CR20","doi-asserted-by":"publisher","unstructured":"J\u00f6rg DJ, Fuertinger DH, Cherif A, Bushinsky DA, Mermelstein A, Raimann JG, Kotanko P (2022) Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types. eLife 11:76228. https:\/\/doi.org\/10.7554\/eLife.76228","DOI":"10.7554\/eLife.76228"},{"key":"1900_CR21","doi-asserted-by":"publisher","unstructured":"Kendler DL, Bone HG, Massari F, Gielen E, Palacios S, Maddox J, Yan C, Yue S, Dinavahi RV, Libanati C, Grauer A (2019) Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab. Osteoporosis Int 30:2437\u20132448. https:\/\/doi.org\/10.1007\/s00198-019-05146-9","DOI":"10.1007\/s00198-019-05146-9"},{"key":"1900_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11914-022-00756-5","volume":"20","author":"AS Kim","year":"2022","unstructured":"Kim AS, Girgis CM, McDonald MM (2022) Osteoclast recycling and the rebound phenomenon following denosumab discontinuation. Curr Osteoporos Rep 20:505\u2013515. https:\/\/doi.org\/10.1007\/s11914-022-00756-5","journal-title":"Curr Osteoporos Rep"},{"key":"1900_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115516","volume":"139","author":"BL Langdahl","year":"2020","unstructured":"Langdahl BL (2020) Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches. Bone 139:115516. https:\/\/doi.org\/10.1016\/j.bone.2020.115516","journal-title":"Bone"},{"issue":"9","key":"1900_CR24","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/bph.15024","volume":"178","author":"BL Langdahl","year":"2021","unstructured":"Langdahl BL (2021) Overview of treatment approaches to osteoporosis. Brit J Pharmacol 178(9):1891\u20131906. https:\/\/doi.org\/10.1111\/bph.15024","journal-title":"Brit J Pharmacol"},{"key":"1900_CR25","doi-asserted-by":"publisher","unstructured":"Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, Engelke K, Finkelstein JS, Genant HK, Goemaere S, Hyldstrup L, Jodar-Gimeno E, Keaveny TM, Kendler D, Lakatos P, Maddox J, Malouf J, Massari FE, Molina JF, Ulla MR, Grauer A (2017) Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet 390(10102):1585\u20131594. https:\/\/doi.org\/10.1016\/S0140-6736(17)31613-6","DOI":"10.1016\/S0140-6736(17)31613-6"},{"issue":"9","key":"1900_CR26","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1007\/s11538-018-0533-0","volume":"81","author":"V Lemaire","year":"2019","unstructured":"Lemaire V, Cox DR (2019) Dynamics of bone cell interactions and differential responses to PTH and antibody-based therapies. Bull Math Biol 81(9):3575\u20133622. https:\/\/doi.org\/10.1007\/s11538-018-0533-0","journal-title":"Bull Math Biol"},{"key":"1900_CR27","volume-title":"Mechanics of Solid Materials","author":"J Lemaitre","year":"1994","unstructured":"Lemaitre J, Chaboche JL (1994) Mechanics of Solid Materials. Cambridge University Press, Cambridge, UK"},{"issue":"20","key":"1900_CR28","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D (2005) Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem 280(20):19883\u201319887. https:\/\/doi.org\/10.1074\/jbc.M413274200","journal-title":"J Biol Chem"},{"issue":"2","key":"1900_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1210\/jc.2013-3278","volume":"99","author":"AH Lierop","year":"2014","unstructured":"Lierop AH, Moester MJC, Hamdy NAT, Papapoulos SE (2014) Serum Dickkopf 1 levels in sclerostin deficiency. J Clin Endocrinol Metab 99(2):252\u20136. https:\/\/doi.org\/10.1210\/jc.2013-3278","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1900_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00198-018-4790-4","volume":"30","author":"S Lou","year":"2019","unstructured":"Lou S, Lv H, Yin P, Li Z, Tang P, Wang Y (2019) Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 30(1):59\u201370. https:\/\/doi.org\/10.1007\/s00198-018-4790-4","journal-title":"Osteoporos Int"},{"issue":"8","key":"1900_CR31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/bdd.770","volume":"32","author":"DD Marathe","year":"2011","unstructured":"Marathe DD, Marathe A, Mager DE (2011) Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women. Biopharm Drug Dispos 32(8):471\u2013481. https:\/\/doi.org\/10.1002\/bdd.770","journal-title":"Biopharm Drug Dispos"},{"key":"1900_CR32","doi-asserted-by":"publisher","unstructured":"Martin M, Sansalone V, Cooper DML, Forwood MR, Pivonka P (2019) Mechanobiological osteocyte feedback drives mechanostat regulation of bone in a multiscale computational model. Biomechanics and Modeling in Mechanobiology 18:1475\u20131496. https:\/\/doi.org\/10.1007\/s10237-019-01158-w","DOI":"10.1007\/s10237-019-01158-w"},{"key":"1900_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115223","volume":"133","author":"M Martin","year":"2020","unstructured":"Martin M, Sansalone V, Cooper DML, Forwood MR, Pivonka P (2020) Assessment of romosozumab efficacy in the treatment of postmenopausal osteoporosis: Results from a mechanistic PK-PD mechanostat model of bone remodeling. Bone 133:115223. https:\/\/doi.org\/10.1016\/j.bone.2020.115223","journal-title":"Bone"},{"key":"1900_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.886579","volume":"10","author":"J Mart\u00ednez-Reina","year":"2022","unstructured":"Mart\u00ednez-Reina J, Calvo-Gallego JL, Martin M, Pivonka P (2022) Assessment of strategies for safe drug discontinuation and transition of denosumab treatment in PMO - Insights from a mechanistic PK\/PD model of bone turnover. Front Bioeng Biotechnol 10:886579. https:\/\/doi.org\/10.3389\/fbioe.2022.886579","journal-title":"Front Bioeng Biotechnol"},{"key":"1900_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2020.104140","volume":"113","author":"J Mart\u00ednez-Reina","year":"2021","unstructured":"Mart\u00ednez-Reina J, Calvo-Gallego JL, Pivonka P (2021) Are drug holidays a safe option in treatment of osteoporosis? - Insights from an in silico mechanistic PK-PD model of denosumab treatment of postmenopausal osteoporosis. J Mech Behav Biomed 113:104140. https:\/\/doi.org\/10.1016\/j.jmbbm.2020.104140","journal-title":"J Mech Behav Biomed"},{"key":"1900_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.635056","volume":"9","author":"J Mart\u00ednez-Reina","year":"2021","unstructured":"Mart\u00ednez-Reina J, Calvo-Gallego JL, Pivonka P (2021) Combined effects of exercise and denosumab treatment on local failure in post-menopausal osteoporosis \u2013 insights from bone remodelling simulations accounting for mineralisation and damage. Front Bioeng Biotechnol 9:635056. https:\/\/doi.org\/10.3389\/fbioe.2021.635056","journal-title":"Front Bioeng Biotechnol"},{"key":"1900_CR37","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Reina J, Garc\u00eda-Aznar J, Dom\u00ednguez J, Doblar\u00e9 M (2009) A bone remodelling model including the directional activity of BMUs. Biomech Model Mechanobiol 8(2):111\u2013127. https:\/\/doi.org\/10.1007\/s10237-008-0122-5","DOI":"10.1007\/s10237-008-0122-5"},{"issue":"3","key":"1900_CR38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jtbi.2008.06.007","volume":"254","author":"J Mart\u00ednez-Reina","year":"2008","unstructured":"Mart\u00ednez-Reina J, Garc\u00eda-Aznar JM, Dom\u00ednguez J, Doblar\u00e9 M (2008) On the role of bone damage in calcium homeostasis. J Theor Biol 254(3):704\u2013712. https:\/\/doi.org\/10.1016\/j.jtbi.2008.06.007","journal-title":"J Theor Biol"},{"key":"1900_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bone.2019.04.022","volume":"125","author":"J Mart\u00ednez-Reina","year":"2019","unstructured":"Mart\u00ednez-Reina J, Pivonka P (2019) Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization. Bone 125:87\u201395. https:\/\/doi.org\/10.1016\/j.bone.2019.04.022","journal-title":"Bone"},{"key":"1900_CR40","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00198-016-3553-3","volume":"27","author":"MR McClung","year":"2016","unstructured":"McClung MR (2016) Cancel the denosumab holiday. Osteoporos Int 27:1677\u20131682. https:\/\/doi.org\/10.1007\/s00198-016-3553-3","journal-title":"Osteoporos Int"},{"key":"1900_CR41","doi-asserted-by":"publisher","unstructured":"McClung MR, Bolognese MA, Brown JP, Reginster JY, Langdahl BL, Shi Y, Timoshanko J, Libanati C, Chines A, Oates MK (2021) Skeletal responses to romosozumab after 12 months of denosumab. JBMR plus 5(7):10512. https:\/\/doi.org\/10.1002\/jbm4.10512","DOI":"10.1002\/jbm4.10512"},{"key":"1900_CR42","doi-asserted-by":"publisher","unstructured":"McClung MR, Brown JP, Diez-Perez A, Resch H, Caminis J, Meisner P, Bolognese MA, Goemaere S, Bone HG, Zanchetta JR, Maddox J, Bray S, Grauer A (2018) Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density: a randomized, double-blind, phase 2, parallel group study. J Bone Miner Res 33(8):1397\u20131406. https:\/\/doi.org\/10.1002\/jbmr.3452","DOI":"10.1002\/jbmr.3452"},{"key":"1900_CR43","doi-asserted-by":"publisher","unstructured":"McDonald MM, Khoo WH, Ng PY, Xiao Y, Zamerli J, Thatcher P, Kyaw W, Pathmanandavel K, Grootveld AK, Moran I, Butt D, Nguyen A, Corr A, Warren S, Biro M et al (2021) Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 184(5):1330\u20131347. https:\/\/doi.org\/10.1016\/j.cell.2021.02.002","DOI":"10.1016\/j.cell.2021.02.002"},{"key":"1900_CR44","doi-asserted-by":"publisher","unstructured":"Miller PD, Bolognese MA, Lewiecki EM, McClung MR, Ding B, Austin M, Liu Y, San Mart\u00edn J (2008) Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone 43(2):222\u2013229. https:\/\/doi.org\/10.1016\/j.bone.2008.04.007","DOI":"10.1016\/j.bone.2008.04.007"},{"issue":"1","key":"1900_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/8755122520967632","volume":"37","author":"SA Miller","year":"2021","unstructured":"Miller SA, St Onge EL, Whalen KL (2021) Romosozumab: a novel agent in the treatment for postmenopausal osteoporosis. J Pharm Technol 37(1):45\u201352. https:\/\/doi.org\/10.1177\/8755122520967632","journal-title":"J Pharm Technol"},{"issue":"10","key":"1900_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nm.2452","volume":"17","author":"T Nakashima","year":"2011","unstructured":"Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H (2011) Evidence for osteocyte regulation of bone homeostasis through rankl expression. Nat Med 17(10):1231\u20131234. https:\/\/doi.org\/10.1038\/nm.2452","journal-title":"Nat Med"},{"issue":"1","key":"1900_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jbmr.173","volume":"26","author":"D Padhi","year":"2011","unstructured":"Padhi D, Jang G, Stouch B, Fang L, Posvar E (2011) Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26(1):19\u201326. https:\/\/doi.org\/10.1002\/jbmr.173","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1900_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0021-9290(94)00156-1","volume":"29","author":"C Pattin","year":"1996","unstructured":"Pattin C, Caler W, Carter D (1996) Cyclic mechanical property degradation during fatigue loading of cortical bone. J Biomech 29(1):69\u201379. https:\/\/doi.org\/10.1016\/0021-9290(94)00156-1","journal-title":"J Biomech"},{"key":"1900_CR49","doi-asserted-by":"publisher","unstructured":"Pivonka P, Calvo-Gallego JL, Schmidt S, Mart\u00ednez-Reina J (2024) Advances in mechanobiological pharmacokinetic-pharmacodynamic models of osteoporosis treatment \u2013 Pathways to optimise and exploit existing therapies. Bone 186:117140. https:\/\/doi.org\/10.1016\/j.bone.2024.117140","DOI":"10.1016\/j.bone.2024.117140"},{"key":"1900_CR50","unstructured":"Prolia (denosumab) [Package insert], (2023). https:\/\/www.medsafe.govt.nz\/profs\/datasheet\/p\/proliainj.pdf"},{"key":"1900_CR51","doi-asserted-by":"publisher","unstructured":"Riggs BL, Melton JL III, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Koshla S (2004) Peterson, J.M., et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 19(12):1945\u20131954. https:\/\/doi.org\/10.1359\/JBMR.040916","DOI":"10.1359\/JBMR.040916"},{"key":"1900_CR52","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3432139\/v1","author":"R Ruiz-Lozano","year":"2024","unstructured":"Ruiz-Lozano R, Calvo-Gallego JL, Pivonka P, McDonald M, Mart\u00ednez-Reina J (2024) An in-silico approach to elucidate the pathways leading to primary osteoporosis: age-related vs. postmenopausal. Biomech Model Mechanbiol https:\/\/doi.org\/10.21203\/rs.3.rs-3432139\/v1","journal-title":"Biomech Model Mechanbiol"},{"key":"1900_CR53","doi-asserted-by":"publisher","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017)  Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377(15):1417\u20131427. https:\/\/doi.org\/10.1056\/NEJMoa1708322","DOI":"10.1056\/NEJMoa1708322"},{"key":"1900_CR54","doi-asserted-by":"publisher","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, L\u00fcthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309\u2013319. https:\/\/doi.org\/10.1016\/s0092-8674(00)80209-3","DOI":"10.1016\/s0092-8674(00)80209-3"},{"key":"1900_CR55","doi-asserted-by":"publisher","unstructured":"Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, Zhao L, Nagy TR, Peng X, Hu J, Feng X, Van Hul W, Wan M, Cao X (2009) TGF-$$\\beta$$1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15:757\u2013765. https:\/\/doi.org\/10.1038\/nm.1979","DOI":"10.1038\/nm.1979"},{"key":"1900_CR56","doi-asserted-by":"publisher","unstructured":"Tourolle DC, Dempster DW, Ledoux C, Boaretti D, Aguilera M, Saleem N, M\u00fcller R (2021) Ten-year simulation of the effects of denosumab on bone remodeling in human biopsies. JBMR Plus 5(6):10494. https:\/\/doi.org\/10.1002\/jbm4.10494","DOI":"10.1002\/jbm4.10494"},{"key":"1900_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtbi.2019.04.020","volume":"473","author":"S Trichilo","year":"2019","unstructured":"Trichilo S, Scheiner S, Forwood M, Cooper DML, Pivonka P (2019) Computational model of the dual action of PTH - Application to a rat model of osteoporosis. J Theor Biol 473:67\u201379. https:\/\/doi.org\/10.1016\/j.jtbi.2019.04.020","journal-title":"J Theor Biol"},{"key":"1900_CR58","doi-asserted-by":"publisher","unstructured":"Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Gua\u00f1abens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC (2017) Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. Bone 105:11\u201317. https:\/\/doi.org\/10.1016\/j.bone.2017.08.003","DOI":"10.1016\/j.bone.2017.08.003"},{"key":"1900_CR59","doi-asserted-by":"publisher","unstructured":"Wijenayaka AR, Kogawa M, Lim HP, Bonewald LF, Findlay DM, Atkins GJ (2011) Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLOS ONE 6 6(10):25900. https:\/\/doi.org\/10.1371\/journal.pone.0025900","DOI":"10.1371\/journal.pone.0025900"},{"key":"1900_CR60","doi-asserted-by":"publisher","unstructured":"Xiong J, Piemontese M, Onal M, Campbell J, Goellner JJ, Dusevich V, Bonewald L, Manolagas SC, O\u2019Brien CA (2015) Osteocytes, not osteoblasts or lining cells, are the main source of the rankl required for osteoclast formation in remodeling bone. PLOS ONE 10(9):0138189. https:\/\/doi.org\/10.1371\/journal.pone.0138189","DOI":"10.1371\/journal.pone.0138189"}],"container-title":["Biomechanics and Modeling in Mechanobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10237-024-01900-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10237-024-01900-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10237-024-01900-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:18:58Z","timestamp":1746519538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10237-024-01900-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1007\/s10237-024-01900-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4719716\/v1","asserted-by":"object"}]},"ISSN":["1617-7959","1617-7940"],"issn-type":[{"value":"1617-7959","type":"print"},{"value":"1617-7940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}